NIM
MIRM icon

NEOS Investment Management’s Mirum Pharmaceuticals MIRM Stock Holding History

NEOS Investment Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,957
Closed -$657K – 666
2025
Q3 		$657K Sell
8,957
-990
-10% -$62.9K ﹤0.01% 558
2025
Q2 		$506K Sell
9,947
-1,485
-13% -$66.1K 0.01% 543
2025
Q1 		$515K Sell
11,432
-6,261
-35% -$295K 0.01% 513
2024
Q4 		$732K Sell
17,693
-26,990
-60% -$1.12M 0.02% 459
2024
Q3 		$1.74M Buy
44,683
+3,439
+8% +$137K 0.05% 286
2024
Q2 		$1.41M Buy
41,244
+14,041
+52% +$368K 0.06% 274
2024
Q1 		$683K Buy
27,203
+19,761
+266% +$543K 0.04% 322
2023
Q4 		$220K Buy
+7,442
New +$225K 0.02% 478

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

NEOS Investment Management's MIRM Position: Q4 2025 in Review

NEOS Investment Management sold out of Mirum Pharmaceuticals (MIRM) in Q4 2025, closing a stake of 8,957 shares — an estimated $657K sold.

NEOS Investment Management first reported a position in MIRM in Q4 2023 and held it in 8 quarters. The position peaked at $1.74M in Q3 2024. 282 funds tracked by Wall St. Rank hold MIRM as of Q4 2025.

  • NEOS Investment Management reported no remaining Mirum Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • NEOS Investment Management sold 8,957 Mirum Pharmaceuticals shares in Q4 2025, an estimated $657K.
  • NEOS Investment Management first reported a position in Mirum Pharmaceuticals in Q4 2023 and held it in 8 quarters.
  • NEOS Investment Management's Mirum Pharmaceuticals position peaked at $1.74M in Q3 2024.
  • 282 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2025.

Based on NEOS Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.